Roshal R. Patel - Concepedia

Author

Roshal R. Patel

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

R. Patel, R.R. Patel, Roshal Patel, Roshal R Patel, Roshal R. Patel, Roshniben Patel

143

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Albany Medical Center Hospital Shandong Tumor Hospital Shandong First Medical University Johns Hopkins Medicine

About

Roshal R. Patel is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, radiation oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1K
2	Health Sciences	4	4	252
3	Immunology	2	2	216
4	Radiation Medicine	2	2	114
5	Health Policy	1	1	17

Roshal R. Patel

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials Willemijn S.M.E. Theelen, Dawei Chen, Vivek Verma, The Lancet Respiratory Medicine MedicineRandomised TrialsImmune Checkpoint InhibitorBronchial NeoplasmCancer Treatment	2020	540
Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials Dawei Chen, Vivek Verma, Roshal R. Patel, International Journal of Radiation OncologyBiologyPhysics Phase 1/2Lymphoid NeoplasiaCancer ImmunosurveillanceRadiation TherapyMedicine	2020	127
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy Dawei Chen, Roshal R. Patel, Vivek Verma, Radiotherapy and Oncology Adaptive RadiotherapySurvival OutcomesOncologyRadiotherapy TechniqueRadiation Therapy	2020	99
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC James W. Welsh, John V. Heymach, Chunxiao Guo, Journal of Thoracic Oncology Phase 1/2OncologyHealth SciencesRadiation TherapyClinical Trials	2020	93
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial Roshal R. Patel, Kewen He, Hampartsoum B. Barsoumian, Radiotherapy and Oncology Radiation MedicinePhase Ii TrialRadiation TherapyHigh-dose IrradiationMedicine	2021	89
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses Hampartsoum B. Barsoumian, Duygu Sezen, Hari Menon, Cancers	2022	37
Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors Roshal R. Patel, Shakti Ramkissoon, Jeffrey S. Ross, Pediatric Blood & Cancer	2020	33
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity Ahmed Younes, Hampartsoum B. Barsoumian, Duygu Sezen, Translational Oncology	2020	29
Food and Drug Administration approvals in phase 3 Cancer clinical trials Joseph Abi Jaoude, Ramez Kouzy, Marc Ghabach, BMC Cancer	2021	26
Management and outcomes of primary anorectal melanoma in the United States Hari Menon, Roshal R. Patel, Taylor R. Cushman, Future Oncology	2020	25

Page 1